COLD
Real Estate

Americold Realty Trust, Inc.

COLD
Since 2006

Headquarters:

GA, United States

Exchange:

NYSE

Industry:

REIT—Industrial

Number of Employees:

14.56K

Current Fiscal Year:

2024

Market Cap:

5.45B

Price per Share:

$19.18

Quarterly Dividend per Share:

$0.22
Year-to-date Performance:
-10.1639%
Dividend Yield:
4.62%
Price-to-book Ratio:
1.62
Trailing P/E Ratio:
N/A

Price History

Latest Prices

DateOpenHighLowClose
2025-05-0119.5319.8119.1319.18
2025-04-3019.8719.9618.8319.34
2025-04-2920.1420.2619.820.1
2025-04-2819.8520.2419.7620.12
2025-04-2520.1120.319.8119.9

Americold is a global leader in temperature-controlled logistics real estate and value added services. Focused on the ownership, operation, acquisition and development of temperature-controlled warehouses, Americold owns and/or operates 245 temperature-controlled warehouses, with approximately 1.5 billion refrigerated cubic feet of storage, in North America, Europe, Asia-Pacific, and South America. Americold's facilities are an integral component of the supply chain connecting food producers, processors, distributors and retailers to consumers.

Financial Performance

2024 Revenue:2.68B

Detailed view of quarterly revenue

2024 Net Income:-284.94M

Detailed view of quarterly net income

2024 Free Cash Flow:119.61M

Overview of free cash flow for the quarter

Annual Revenue Comparison

Compares total annual revenues

Similar Companies

Industrials
CYRX
Cryoport, Inc.
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.
269.89M
Market Cap
*Data based on the last 12 months.